Come up with a name for your new list and we'll add to it:
Coherus BioSciences raised a round of funding on March 10, 2011. Investors include
MX II Associates.
Coherus is a biologics platform company focused on delivering high-quality biosimilar therapeutics that will expand patient access to life-changing medications worldwide. Headquartered in the San Fran…